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Validated tools are lacking in languages like French to diagnose ADHD in adults. The Adult 
ADHD symptoms Self-Report (ASRS) was filled out by 1,171 parents of 900 school-aged youths in 
the context of the Children and Parents with ADHD and Related Disorders study. Prevalence estimates 
based on three scoring methods are compared (6-item screener, all 18 items, or the screener followed 
by the 12 remaining items). Based on the recommended and more conservative scoring method, the 
overall prevalence of ADHD symptoms is estimated to be 2.99%, without significant group 
differences between genders, or between younger and older adults. Potential correlates of ADHD 
symptoms were also examined in their relatives (children, brothers/sisters, uncles/aunts, and parents): 
birth order, level of education, body mass index categories, enuresis, suicide attempts, depression, and 
learning disabilities. Adults can be screened for ADHD symptoms using the ASRS; negative long-
term outcomes should be assessed in patients’ relatives too. 
 





Attention-Deficit with Hyperactivity (ADHD) is one of the most frequent disorder in children and 
adolescents with a worldwide mean estimated prevalence of 5.29% (Polanczyk et al, 2007). According 
to DSM-IV, this condition encompasses a number of pervasive and impairing symptoms including 
severe problems of inattention and/or hyperactivity and impulsivity 
(American Psychiatric Association, 1994). The World Health Organization’s (WHO) ICD-10 uses the 
name of Hyperkinetic Disorder (HKD) and lists similar criteria (Word Health Organization, 1993), but 
has a more stringent diagnostic algorithm leading to a lower prevalence of HKD than ADHD 
(Polanczyk et al, 2007). According to DSM-IV, three types of ADHD can be distinguished according 
to whether the symptoms are predominantly characterized by inattention, hyperactivity-impulsivity, or 
both (American Psychiatric Association, 1994). Studies suggest that the Predominantly Inattentive 
subtype may constitute a distinct disorder (Caci et al, 2013 (Ahead of print); Capdevila-Brophy et al, 
2013 (Ahead of print); Solanto, 2000). 
Although it is stipulated by both diagnostic systems that ADHD symptoms are pervasive, and 
tend to persist into adulthood for two third of the cases (Biederman et al, 2010; Faraone et al, 2006a; 
Klein et al, 2012; Kooij et al, 2010), neither the DSM-IV nor the ICD-10 provide specific criteria for 
adults (Barkley et al, 2008). Adult prevalence rates of ADHD are estimated to be between 2.5% and 
3.4% in the general population (Fayyad et al, 2007; Simon et al, 2009)1. This condition is associated 
with a broad range of negative life outcomes but is also responsive to treatment (Hodgkins et al, 2012; 
Shaw et al, 2012), pointing to the need for efficient screening and diagnosis procedures. Illustrative of 
this need, the European Network for Adult ADHD recently proposed the DIVA, a semi-structured 
interview for ADHD, adapted in many languages and free of charge for clinicians and researchers 
(DIVA Foundation, 2012). However, semi-structured interviews are costly to use in epidemiological 
                                               
1 It should be noted that the estimates reported by Fayyad et al. (2007) are based on a complex scoring algorithm 
whereby each of their 11,422 subjects provided retrospective assessments of childhood ADHD. For those 
retrospectively classified as having met ADHD criteria in childhood, a single item screener was used to asses 
likely current levels of ADHD. Then a random sample of 154 respondents underwent a complete one-on-one 
clinical reappraisal interview of current ADHD. For all the remaining participants, multiple imputation 
procedures were used to estimate the likely conclusions of this reappraisal based on all provided information.  
 
 
research and not well suited to large scale screening procedures. 
In 2000, the World Health Organization (WHO) designed a questionnaire to rigorously assess 
ADHD symptoms in adults (the Adult ADHD symptoms Self-Report v1.1, ASRS) that only includes 
18 items rated on a 0 (Never) to 4 (Very often) scale and no item related to the age of onset, duration, 
and impairment criteria. It has been adapted to up to ten languages (see 
http://www.hcp.med.harvard.edu/ncs/asrs.php). The French adaptation was done following a classical 
translation-back-translation procedure. The resulting version was approved by the WHO as the official 
French version of the full ASRS (Caci et al, 2008). Since the initial American validation study that 
supported the adequacy of a reduced form of the ASRS as a screening tool for ADHD (Kessler et al, 
2004a), the full ASRS has been used also in clinical samples with comorbid conditions (Adler et al, 
2009), in clinical trials to monitor changes in adults, and, more recently, in adolescents (Adler et al, 
2011; Adler et al, 2012). Epidemiological studies using face-to-face interviews yielded the 
computation of mean cross-national prevalence rates in adults that reaches 3.4% (inter-quartile range: 
1.3-4.9%) (de Graaf et al, 2008; Fayyad et al, 2007; Kessler et al, 2006), and the ASRS showed strong 
concordance with clinician diagnoses (Kessler et al, 2005; Kessler et al, 2007). Surprisingly, one of 
these studies reported a point-estimate of 7.3% (s.e.=1.8%) in France (N=727), with “the lower end of 
the 95% confidence interval of this estimate above the prevalence estimate for the total sample” 
(Fayyad et al, 2007). This is a striking result for France, a country where awareness of ADHD is low 
given a long history of psychoanalytic dominance in psychiatric practice which excluded ADHD as a 
meaningful diagnosis (Gonon et al, 2010). The main objective of this paper is to report on the rates of 
symptoms prevalence observed among samples of French adults from the general population in order 
to see whether this result could be replicated. When rating a questionnaire, a symptom is often rated as 
present if the score on the corresponding item is greater or equal than a predetermined cut-off score, 
and absent otherwise (Gomez et al, 2011). Then, the symptoms deemed present by this method are typically 
added. This simple method is criticisable as it may lead to false positive cases and increased prevalence 
estimates of both symptoms of ADHD and ADHD. Furthermore, for use in epidemiological studies, it 
is often useful to have access to more sophisticated rating algorithms involving the use of a shorter 
screener to determine who really need to complete a fuller instrument, leading to a two-step procedure 
 
 
such as the one proposed for the ASRS (Kessler et al., 2005). However, meeting symptom criteria on a 
rating scale doesn’t guarantee that the person fully correspond to a clinical diagnosis of ADHD since 
the person would also have to meet the clinical significance or impairment criterion (criterion D). 
Accordingly, some authors reported that impairment is moderately related to symptoms, and clinically 
probably more important than symptoms (Gordon et al, 2006; Molina et al, 2009).  
In both children and adults, ADHD is a condition characterized by its heterogeneity (Wahlstedt et 
al, 2009) and by the high frequency of comorbid diagnoses (Brown, 2009) that lead to a variety of 
short-term and long-term personal and familial outcomes (Hodgkins et al, 2012; Shaw et al, 2012). In 
this study, we also investigate the association between ADHD, demographic characteristics (e.g., 
gender, age, birth order) and disorders (e.g., overweight/obesity, enuresis) known to be highly 
comorbid with ADHD. 
Among the demographic characteristics most clearly associated with ADHD, sex and age clearly 
come first. Indeed, the specific manifestations of ADHD are known to differ as a function of age and 
sex, and prevalence rates are known to decrease with age and to be higher among males than females 
(Barkley et al, 2008; Caci et al, 2013 (Ahead of print); Faraone et al, 2006a; Faraone et al, 2006b). 
Birth order is also considered to represent a very influential demographic factor in child development 
and, as such, was put forward as a risk for developing ADHD as well as other disorders (Birtchnell, 
1971). Results of studies on ADHD are controversial (Marin et al, 2012 [Epub ahead of print]) but 
overall tend to show the absence of relations between ADHD and birth order (Berger et al, 2009). 
However, most studies focused on children and adolescents, pointing to the need to investigate if the 
potential effect of this factor could emerge later on in the development.  
Because hyperkinesia is not only observed in ADHD but also other conditions such as anorexia 
nervosa (Vansteelandt et al, 2004), one representation in lay people is that hyperactivity causes 
thinness as it involves high levels of energy consumption. Furthermore, underweight might also result 
from pharmacological treatment because one the most frequent side effect of these treatments is a loss 
of weight through appetite decrease (Poulton et al, 2012). An epidemiological study reported that US 
children with ADHD had about 1.5 times the odds of being overweight before they received any 
pharmacological treatment for their ADHD, and 1.6 times the odds of being underweight once they 
 
 
had started pharmacological treatment (Waring et al, 2008). Binge eating and bulimia behaviours are 
also known to be related to high levels of impulsivity (Wonderlich et al, 2004) and ADHD (de Zwaan 
et al, 2011; Mikami et al, 2010; Surman et al, 2006). Conversely, a recent study reported that 
overweight problems for adolescents with ADHD tend to persist into adulthood (McClure et al, 2012), 
with prevalence rates of ADHD in adults receiving treatment for obesity reported as varying between 
27.4% (CI95%=[21.1; 32.9]) and 42.6% (CI95%=[36.3; 48.9]) (Altfas, 2002).  
In relation to this possible association between overweight and ADHD, a recent cross-sectional 
study also showed that obese children presented an increased risk for enuresis and recommended that 
potential enuresis should be screened during the initial set-up of interventions with obese children and 
adolescents (Weintraub et al, 2013). This study also replicated results from previous studies (Baeyens 
et al, 2004; Baeyens et al, 2007), showing that enuresis tends to be comorbid with ADHD, especially 
in boys. Both disorders are heritable but enuresis tends to disappear with increasing age while ADHD 
does not (Aubert et al, 2010). A recent review of the literature report that 20% of ADHD children also 
had primary nocturnal enuresis and, conversely, that 10% of children with enuresis also had ADHD 
(Aubert et al, 2010), leading to the recommendation to systematically screen for ADHD during 
consultations for enuresis and vice versa. Here, we extend these studies to investigate the relations 
between ADHD symptoms, overweight and enuresis during adulthood.  
Impulsivity, a significant characteristic of ADHD, is a well-recognized factor risk for suicide 
attempts (Caci et al, 2004b). For instance, follow-up studies in early adulthood of children diagnosed 
with ADHD yield an overall estimated suicide rate about .7% that corresponds to a relative risk ratio 
of 2.91 (James et al, 2004). Compared with controls, patients with ADHD are 2.4 times more likely to 
make a voluntary self-injury and 2.9 more likely to attempt suicide (Swensen et al, 2002). The 
frequent comorbidity between ADHD and depression is also suspected to play a role in the association 
between ADHD and suicide attempts, especially in male adolescents (James et al, 2004). Similarly, 
parental psychopathology and genetic predispositions are recognized risk factors for ADHD in 
offspring (Galéra et al, 2011; Lindblad et al, 2011) but, to our knowledge, the link between parental 
ADHD and suicide/suicide attempt in offspring has never been assessed. 
One of the major long-term outcomes of ADHD is that affected individuals are at higher risk of 
 
 
attaining a lower level of education than non-ADHD, potentially due to the comorbidity between 
ADHD and learning difficulties (Klein et al, 2012; Mannuzza et al, 1993) but also because impairment 
in functioning (foremost school and social functioning) are part of the clinical picture of ADHD. In a 
33-year follow-up study (Klein et al, 2012), probands attained 13.3 (s.d.=2.1) years of education vs. 
15.8 (s.d.=2.3) for controls [t(269)=9.52; p<.01; Cohen’s d=1.139]. Controls completed a bachelor’s 
degree (34.6%) or higher degree (29.4%) vs. 15.6% and 3.7% in probands [χ 2(1)=13.02 and 
χ2(1)=32.33, respectively; p<.01]. 
Aims of the study 
The principal aim of our study is to estimate the prevalence of ADHD symptoms in a French 
community sample using the full ASRS and look for an effect of sex and/or age. We predict that 
ADHD symptoms at adulthood will be more frequent in males, show a slight decrease as a function of 
age, and will be significantly associated with weight problems, enuresis, suicide attempts, depression, 
learning difficulties and lower educational achievement in both self and relatives. 
MATERIAL AND METHODS 
Study design 
This paper is based on data from the Children and Adults with ADHD and Related Disorders 
(ChiP-ARD) study that was conducted in southern France (Caci et al, 2013 (Ahead of print); Morin et 
al, 2013 (Ahead of print)). This study is the largest study in France concerned with ADHD symptoms 
in a community sample, and one of the larger studies ever conducted in Europe. This study received 
the support of the Commissioner of Education and the Department of Education, complied with 
normative ethical prescriptions for French medical research, and the procedures used to keep paper-
based and electronic data secured and anonymous were approved by the Commission Nationale 
Informatique et Liberté. 
Parents of the youths participating in this study had to return a signed consent form and were 
asked to complete questionnaires, including the ASRS in relation to their own manifestations of 
ADHD. Since the participation in the study was voluntary and strictly anonymous, we have no access to 
the characteristics of the non-respondents. Overall, 1,171 adults mailed back completed questionnaires to 
the research site and form the main sample used in this study, but twelve (9 women and 3 men) did not 
 
 
report their month and/or their year of birth. Women (n=651; Mage = 40.73; S.D. = 5.60; range = 
22.00-59.17) were younger [t(1023.4)=-6.85 (p<.0001, Cohen’s d=.412] than men (n=507; Mage = 
43.16; S.D. = 6.28; range = 26.17-64.67). In order to test for the effect of age on prevalence, we 
divided the sample into younger (20 to 40 years old; n = 425) and older adults (40 to 65 years old; n = 
733). 
Participants (n=1,142, excluding participants with missing data on these variables and seven 
pregnant women) provided us with ratings of the height and weight, from which we computed their 
Body Mass Index (BMI, defined as the ratio of body weight in kilograms over squared body height in 
meters). Regardless of age and sex, the WHO definition for overweight is a BMI greater or equal to 
25, and for obesity a BMI greater than 30 (http://who.int/mediacentre/factsheets/fs311/en/). Similarly, 
underweight is defined by a BMI lower than 18.50. Admittedly, BMI should be considered a rough 
guide because it may not correspond to the same level of body fat in different individuals. 
The higher attained level of education was reported in a six-category format to match French 
census data of 2009 established as follows: (i) Participants who completed primary school (i.e., 
Certificat d’Études Primaires) or less were coded 0; (ii) those who completed secondary school (i.e., 
BEPC, Brevet Élémentaire, Brevet des Collèges) were coded 1; (iii) those who completed a 
professional certificate (i.e., Certificat d’Aptitude Professionnel) or diploma (i.e., Brevet d’Études 
Professionnelles) were coded 2; (iv) those who completed college (i.e., Baccalauréat) or obtained a 
professional degree (i.e., Brevet Professionnel) were coded 3; (v) those who completed undergraduate 
university studies (i.e., premier cycle universitaire, License), where coded 4; and (vi) those who 
completed graduate university studies (i.e., deuxième ou troisième cycle universitaire, Maîtrise, 
Doctorat) were coded 5.  
We explored the personal and familial history using simple Yes/No questions pertaining to the 
participants themselves and to any of their relatives (children, brothers/sisters, and parents). We asked 
if they or any of their relative ever attempted or committed suicide, suffered from depression, had 
learning difficulties, and had enuresis. We adopted a highly conservative approach by assimilating 
non-responses to negative answers and, when applicable, we discarded those participants who were 
likely to be single children (N=145). 
 
 
The ASRS  
The performance of the ASRS was assessed after thorough weighting of a subsample of 154 
adults included in the US National Comorbidity Survey Replication (NCS-R) (Kessler et al, 2004b) 
aged between 18 and 44 years-old (Kessler et al, 2005). This age limit was chosen because older 
participants were deemed to present too much risk of experiencing memory bias when recalling 
ADHD symptoms in childhood. Item scores were dichotomized: 11 items were scored 1 if the 
response was Often or Very Often, and the remaining 7 items were score 1 if the response was 
Sometimes, Often or Very Often (Kessler et al, 2005). The simplest scoring method of the full ASRS is 
to sum the dichotomized items and consider people with a count of at least 9 points as positive for 
ADHD (Kessler et al, 2006). Doing so, sensitivity is 56.3% and specificity is 98.3% when compared 
to structured diagnostic interview ratings. Six items (4 inattention and 2 hyperactivity-impulsivity 
symptoms) were then selected by stepwise logistic regressions as those that most accurately predicted 
the clinical diagnostic classification (Kessler et al, 2005). These six items present a sensitivity of 
68.7%, a specificity of 99.5%, and form the ASRS-screener. A two-step procedure was suggested to 
further improve the performance of the ASRS: the sum of the 18 dichotomized items is computed only 
for those subjects who scored higher than 3 on the 6-item screener, and those who received a total 
score higher than 10 are considered as very likely to have ADHD. These procedures convey more 
information than a simple sum of item scores as the 18 items were weighted and the six items of the 
screener selected to improve both the sensibility and the specificity against a clinical diagnosis that 
included the assessment of criteria A-D. This makes the diagnosis of ADHD highly probable albeit not 
certain. 
Analyses 
Data were analysed using STATA/SE 9.2 (Stata Corp., 2007). Of the 1,175 booklets returned by 
parents, ASRS was empty in 4 cases; 75 other cases had at least one missing item (6.41%) and 56 
cases had only one item missing item (4.78%). Given the pattern and rarity of missing values, we 
performed an imputation by chained equations (van Buuren et al, 1999; White et al, 2011) yielding a 
final sample of 1,171 complete observations.  
To estimate the prevalence of ADHD symptoms, we first dichotomized the items as 
 
 
recommended by the authors of the ASRS (Kessler et al, 2005). Maximum Likelihood estimates of the 
point-value of prevalence rates reflecting the ratio (X/n) of the number of subjects who qualify for a 
diagnostic (X) on the total number of subjects (n), together with a 95% Confidence Interval, will be 
reported for the full sample and for the sex and age specific subgroups. We will report those values 
based on the ASRS 6-item screener, the full ASRS and the two-stage screening process. All 
computations were done using an online calculator (http://www.measuringusability.com/wald.htm) 
(Lewis et al, 2006; Sauro et al, 2005). 
RESULTS 
Prevalence of ADHD symptoms, age and sex 
According to the 2009 Census data, the city of Nice intra muros counts 191,199 inhabitants 
(90,791 men; 47.49%) between 20 and 64 years old. Our sample counts overall slightly less men 
[43.55%, χ2(1)=7.218, p<.007] but more men of at least 40 years old [31.17% vs. 25.78%; 
χ2(1)=58.074; p<.001] and the same proportion of women of at least 40 years old [32.12% vs. 29.39%; 
χ2(1)=.367; n.s.]. 
Table 1 presents prevalence estimates for the entire sample and for sex, age and sex-by-age 
subsamples. The entire sample prevalence of ADHD symptoms is 11.27% when using the 6-item 
screener alone, 8.37% when based on the full ASRS scale, but falls to 2.99% when using the 
recommended two-stage scoring algorithm. There is no significant sex and age effect on scores 
obtained on the 6-item screener (Fisher’s exact test p=.403, and Spearman’s rho=.031, n.s., 
respectively), on the full ASRS scale (Fisher’s exact test p=.395, and Spearman’s rho=.029, n.s., 
respectively), or on the two-stage score (Fisher’s exact test p=.388, and Spearman’s rho=.049, n.s., 
respectively). These results suggest that age and sex differences commonly reported in childhood and 
adolescence may fade out in adulthood (Kooij et al, 2010). Rates of prevalence were also computed on 
the non-imputed data and were almost identical to those reported here (these alternative rates are 
available from the first author). 
When looking at the participants who screened positive on the 6-item screener (n=132), 61 had 
less than 6 positive items on the total ASRS scale, 60 had at least 6 positive items of either inattention 
 
 
or hyperactivity-impulsivity (i.e., 50 were likely to correspond to the predominantly Inattentive 
subtype and 10 likely to correspond to the predominantly Hyperactive-Impulsive subtype), and 11 had 
at least 6 positive items of both inattention and hyperactivity-impulsivity (i.e., combined subtype), 
likely to correspond to the 
When looking at the participants who screened positive in the second stage (n=35), 24 had at least 
6 positive items of either inattention or hyperactivity-impulsivity (i.e., 21 likely to correspond to the 
predominantly Inattentive subtype and 3 likely to correspond to the predominantly Hyperactive-
Impulsive subtype), and 11 had at least 6 positive items of both inattention and hyperactivity-
impulsivity (i.e., likely to correspond to the combined subtype). Table 1 shows estimates of prevalence 
split by gender, age, and age-by-gender for ADHD subtypes. 
The following regression analyses contrast the subgroup of individuals found positive using the 
two-stage algorithm versus the rest of the sample. 
ADHD symptoms and birth order 
Our sample includes 24 twins and none of them presented significant levels of ADHD symptoms. 
Non-twins participants who were their mother’s first-born are not significantly more likely to present 
clinically significant levels of ADHD (OR=.196, s.e.=.200, CI95=[.027; 1.446]) than the other 
participants, whatever their sex (OR=1.411, s.e.=.485, CI95=[.719; 2.769]). 
ADHD symptoms and BMI 
Table 2 shows the prevalence of the BMI categories as defined by the WHO. Examination of 
these prevalence rates show that: (i) no participant presented significant levels of ADHD symptoms in 
the Underweight group, (ii) the prevalence of having a Normal BMI is lower for participants 
presenting ADHD symptoms than for those without, and (iii) the prevalence of being Overweight and 
Obese are about twice as high for participants with ADHD symptoms than for those without. 
Compared to US rates, the Underweight and Obese categories are far less prevalent in our sample 
(Pagoto et al, 2009). 
More precisely, the results reveal a trend for participants with ADHD symptoms in presenting a 
higher risk of being overweight rather than normal (OR=2.052, p<.08, CI95=[.923; 4.565]) after 
controlling for sex (OR=3.944, p<.001, CI95=[2.918, 5.330]) and age (OR=1.039, p<.002, 
 
 
CI95=[1.014; 1.065]). The results also show a similar trend for participants with ADHD symptoms in 
presenting of higher risk of obesity (OR=2.536, p<.08, CI95=[.889; 7.231]) after controlling for sex 
(OR=2.295, p<.001, CI95=[1.461; 3.605]) and age (OR=1.018, n.s., CI95=[.980; 1.058]). There is no 
effect of ADHD symptoms, sex and age when comparing obese to overweighed participants. 
ADHD symptoms and level of education 
Table 3 presents participants’ levels of education split by sex and age group for the current 
sample and for the population of Nice in the 2009 French National census. Comparisons show a 
significant difference for men: our sample includes more men older than 40 years with at least a 
college degree [χ2(1)=31.032; p<.001)] than census data. For women, the results show an interaction 
effect [χ2 (1)=4.027; p<.046)] showing that in our sample, fewer women older than 40 years have an 
education level lower than grade 12 and more women older than 40 years have a university degree, 
when compared to census data. Thus, overall, our sample tends to be more educated than the general 
population of Nice. 
In our sample, ADHD symptoms are not associated with achieving Grade 12 or higher levels of 
education (OR=.657; n.s.; CI95=[.328; 1.318]) nor age (OR=1.103; n.s.; CI95=[.851; 1.428]) but that 
there is a significant effect of sex showing that females tend to achieve higher levels of education than 
males (OR=.557; p<.001; CI95=[.434; .715]). ADHD symptoms are also not associated with 
university completion (OR=1.113; n.s.; CI95=[.561; 2.210]) or age (OR=1.229; n.s.; CI95=[.964; 
1.568]) but there is a significant effect of sex showing again that females tend to achieve higher levels 
of education than males (OR=.705; p<.004; CI95=[.557; .894]). 
Personal and familial history of adults with ADHD symptoms 
Table 4 presents the results from the associations of various comorbidities and ADHD symptoms. 
Adults screened positive on the ASRS strongly acknowledged that they have ADHD (OR=17.562; 
p<.023; CI95=[1.525; 202.196]) regardless of age and sex. These adults with likely ADHD diagnosis 
are almost 5 times more likely than those without to have a learning disorder regardless of age and 
sex, and four times more likely to report a previous episode of depression (with women presenting 
higher risk of depression than men). Although the odds-ratio is not significant, participants with 
ADHD are also two times more likely to have attempted suicide (s.e.=2.272, CI95=[.662; 13.305]) and 
 
 
their siblings are 6 times more likely to have attempted or committed suicide. ADHD symptoms are 
also significantly related with enuresis in the informant regardless of sex, as well as in their children. 
Overall, lifetime enuresis is acknowledged by 4.78% of the adult informants, and by 4.87% of their 
children. An additional analysis even showed a significant effect of parental sex, ADHD symptoms 
and enuresis on child’s likelihood of reporting enuresis, although these results also differed according 
to the gender of the parents. For instance, ADHD symptoms (OR=6.194, p<.002, CI95=[1.996; 
19.221]) but not enuresis (OR=1.858, p<.306, CI95=[.568; 6.084]) in mothers was significantly 
associated with a higher risk of enuresis in children. Conversely, enuresis (OR=6.089, p<.004, 
CI95=[1.773; 20.909]) but not ADHD symptoms (OR=3.157, p<.171, CI95=[.609; 16.362]) in fathers 
was associated with a higher risk of enuresis in the children. 
DISCUSSION 
Our study is the first to report the prevalence rate of ADHD symptoms in a large community 
sample of French adults using all 18 items of a validated self-report questionnaire. However, given 
that the study design did not allow us to access characteristics of the non-respondents, it is impossible 
to rule out the possibility that a selection bias may have influenced the results. It may be that the non-
respondents could not complete the questionnaire for insufficient mastery of the French language, did 
not take the study seriously enough, had more busy lifestyle, but also that they presented higher levels 
of ADHD, making it harder for them to sit still and concentrate on a questionnaire. For this reason, it 
is possible that our prevalence estimates may have been slightly inflated as a result of this design 
characteristic. Similarly, we cannot be fully confident that our sample is fully representative of the 
French population, which is not unexpected given the nature of the recruitment design. However, our 
sample remains large (N=1,171) and reasonably comparable to the 2009 Census data for the city of 
Nice, although slightly more educated. Finally, we controlled for age and sex whenever applicable to 
ensure that the results were not due to possible differences in this regard between our sample and the 
global population of Nice in 2009. 
Self-rated screening tools are generally expected to yield upward biased prevalence estimates for 
three main reasons. First, the presence of a clinician is generally required to make the diagnoses as 
objective and closely related to common diagnostic criteria as possible. Second, self-report 
 
 
instruments, as it is the case for the ASRS, very seldom include a comprehensive coverage of all 
diagnostic criteria (i.e., age at onset, duration, functional impairment, and exclusion diagnoses). Third, 
self-report instruments like the ASRS do not include any information about the emergence of the 
disorder into childhood, or about its occurrence in multiple contexts, two important facets of ADHD. 
To partly overcome these issues a more stringent two-step scoring method must be used. Undoubtedly, 
our results show that relying solely on the 6-item screener yields an unrealistic prevalence estimate of 
11.27% that cannot be explained by sample bias. However, this screener was never proposed to permit 
valid diagnoses of ADHD, but rather to allow for a comprehensive screening of participants for more 
extensive evaluations procedures. Similarly, simply using the full-scale score also yield unreasonably 
high prevalence estimates (8.37%), although these appear to be in line with at least one previous 
estimate (Fayyad et al, 2007). However, the alternative two-stage scoring method using all 18 items 
yields a more realistic prevalence of 2.99% in adults from the community, similar to values reported in 
previous International studies using face-to-face clinical interviews for diagnosis (de Graaf et al, 2008; 
Fayyad et al, 2007; Kessler et al, 2006). These results apparently support the efficacy of this two-step 
procedure in identifying participants that should be targeted for more extensive evaluations (6-item 
screener) and then to identify those most likely to correspond to ADHD scoring criteria in a second 
step. Clearly, although this distinction is important in the way results from self-reports on the ASRS 
are computed, they have even greater relevance to web-based research or screenings protocols. Indeed, 
the efficacy of the two-step procedures suggest that a stem (6-item screener) and leaf (12 remaining 
items) protocol could be implemented so that all participants only have 6-items to answer and only a 
few (12%) have to complete an extended set of ADHD items. Further studies are needed to investigate 
the efficacy of this two-step procedure in identifying clinical levels of ADHD, as well as its rates of 
sensibility and specificity when compared to structured clinical interviews, such as the Diagnostic 
Interview for Adult ADHD (DIVA 2.0) recently developed by the European Network for ADHD in 
Adults (http://www.divacenter.eu). 
With regard to group comparisons, they showed ratios of 1.37 for men:women, 1.39 for older: 
younger adults, 1.25 for older:younger women, and 1.15 for older:younger men. Overall, the ADHD 
symptoms prevalence estimates in our sample did not vary with sex or age, suggesting that commonly 
 
 
reported age and sex differences in youths’ levels of ADHD may fade out upon entry into adulthood. 
This observation is consistent with previous studies. It is generally acknowledged that the sex ratio is 
about 3:1 in youths but tends to equilibrate in adults. For instance, the World Mental Health 
international survey conducted in 10 countries reported a men:women sex-ratio of 1.7, close to the 
value reported here (de Graaf et al, 2008), and a 1.6:1 sex ratio was reported in the National 
Comorbidity Survey-Replication (Kessler et al, 2006).  
In addition, although we found ADHD symptoms to be unrelated to educational attainment itself, 
the observed odds-ratio suggested a lower level for participants with ADHD. This negative result is 
quite unusual as ADHD into childhood is reputed to increase the risk for lower educational attainment 
(Hodgkins et al, 2012). Other epidemiological studies have also reported similar results: for example, 
the World Mental Health international surveys conducted in 10 countries reported no overall effect of 
ADHD symptoms on educational attainment (de Graaf et al, 2008). Outside of clinical samples this 
relation becomes less clear because (i) participants may present less severe symptoms (e.g. with 
successful adaptive behaviors, higher IQs or more effective executive functioning), and (ii) most 
severely affected individuals may have declined to participate in epidemiological survey, especially in 
a study such as this one where the main target was the child, and not the parent. Significant deficits of 
executive functioning affects about one-third of adults with ADHD symptoms leading to more a 
severe functional impairment, lower socioeconomic status and lower educational attainment in these 
doubly affected adults than among adults with ADHD symptoms but no deficits in executive 
functioning (Biederman et al, 2006). Our observation may also be related to the specific sample used 
in the present study, which presents slightly higher levels of education than the 2009 Census 
population of Nice. Another explication may be that more educated participants endorse ADHD items 
more frequently because of their style of life or occupation. However, although participants with 
ADHD symptoms did not significantly differ from those without regarding the levels of education 
attainments, they did report substantially higher levels of learning difficulties, clearly supporting the 
results from previous studies (Seidman et al, 1998), showing that at least achieving the same 
educational outcomes might have proven to be more challenging than for people without ADHD 
symptoms. This finding should be investigated in further studies in which executive functioning is 
 
 
taken into consideration. 
One study recently reported that first-born children were twice likely to have ADHD (Marin et al, 
2012 [Epub ahead of print]) while most reports did not find relations between birth order and ADHD 
(Berger et al, 2009). All these studies investigated clinical samples. To our knowledge, no study 
examined this issue in community adults. In our sample, there was clearly no increased risk for first-
borns regardless of their sex to present ADHD symptoms. Our results thus support previous findings 
of a lack of relation between ADHD and birth order. 
We estimated the risk for overweight and obesity associated with ADHD symptoms. The 
prevalence for these two categories of weight related problems are very low in our sample but are 
nevertheless twice as high in the group with ADHD symptoms that in the group without. Due to the 
resulting lack of statistical power, we are only able to show a trend for a higher likelihood of 
overweight (OR=2.052) and obesity (OR=2.536) in the group with ADHD symptoms. No data was 
available regarding participants socio-economic status (SES), which may be a confounder in the 
relationship between ADHD symptoms and overweight/obesity. However, it should be noted that this 
possible confounding impact has yet only been noted, to our knowledge, in a nationally representative 
and community based survey of German children and adolescents (Erhart et al, 2012). A study on 6,735 U.S. 
residents revealed that adults with ADHD were significantly more at risk of being overweight 
(OR=1.58; CI95=[1.05; 2.38]) and obese (OR=1,81; CI95=[1.14; 2.64]) (Pagoto et al, 2009), albeit the 
odds ratio were much lower than those reported here. The possible reasons for an association between 
overweight/obesity and ADHD symptoms are numerous (Davis et al, 2006; Nazar et al, 2008; Nazar et 
al, 2012 [Epub ahead of print]). For instance, the role of low central dopamine has been suggested: 
this neurotransmitter is involved in both appetite regulation (Stice et al, 2011) and inhibition control 
(i.e. inhibition of distraction and inhibition of behaviour) (Ghahremani et al, 2012). Also, weight 
regulation may be challenging for individuals with ADHD symptoms who may have difficulties in 
planning meals ahead of time, may more frequently skip meals and may lose sight of intentions to 
moderate food intake due to their ADHD symptoms (Docet et al, 2012). The role of circadian rhythms 
may also be suspected since evening orientation is also associated with eating disorders (Natale et al, 
2008), impulsivity and novelty seeking (Caci et al, 2005; Caci et al, 2004a), as well as ADHD 
 
 
symptoms (Caci et al, 2009; Xu et al, 2010). A proposed relation between excessive daytime 
sleepiness, that is associated with ADHD symptoms, and obesity (Cortese et al, 2008) might also be 
incorporated within a chronobiological framework of the relations between these two disorders. 
Finally, sleep apnea are more likely to occur in persons suffering from obesity, and may also cause 
daytime sleepiness and cognitive impairment mimicking ADHD symptoms (Philipsen et al, 2006). 
We also found original results regarding the associations between enuresis and ADHD symptoms 
in the participants themselves and their offspring. Enuresis is suspected to have a genetic origin 
because of familial aggregation: biological parents often report to have had enuresis as a child when 
their offspring are referred for enuresis (Aubert et al, 2010). Like ADHD, enuresis shows a sex ratio of 
about 3 boys for 1 girl. Like ADHD, enuresis also tends to persist at adulthood although the rate is 
about 3% much lower than the rate for ADHD. Here, participants with ADHD symptoms report higher 
rates of enuresis for themselves and their offspring. In both cases, the OR is greater than 5 with the 
upper limit of the CI95 greater than 13. This is consistent with the literature (Aubert et al, 2010; 
Baeyens et al, 2006; Baeyens et al, 2005; Baeyens et al, 2004). However, this relation appears to be 
true only for mothers. In contrast, the odds for enuresis in youths are higher if the father himself had 
enuresis, but not if he has ADHD. These findings support the comorbidity of ADHD and enuresis but 
also the idea of different pathophysiological pathways of familial transmission for these two disorders. 
Clearly, future research should look at the interplay between ADHD, enuresis and overweight/obesity 
in a developmental framework (Weintraub et al, 2013). 
Finally, we observed a consistent pattern of findings regarding the associations between ADHD 
symptoms and depression. In a related way, although only two of 27 suicide attempters were classified 
as presenting ADHD symptoms, we did find that offspring and brothers/sisters of parents with 
possible ADHD presented a higher risk of attempting suicide. This supports the conclusion from a 
previous study showing that ADHD was not a direct predictor of suicide attempts in adults, where 
comorbid conditions seemed to play a stronger role (Agosti et al, 2011). Nevertheless, our study is the 
first to report that offspring of participants with ADHD symptoms presented 18 times the odds of 
attempting suicides than offspring of non-ADHD parents. Although this was not a main objective of 
the present study, this result clearly should be investigated in future studies and, if replicated, should 
 
 
be used to develop targeted preventive interventions. 
CONCLUSIONS 
The two-stage scoring algorithm for the ASRS outperforms the other two methods in identifying 
probable ADHD cases. We found no significant gender effect on prevalence, and there was a trend for 
an association between overweight/obesity and ADHD symptoms. There are two major clinical 
implications of this study. First, we reported an association between ADHD symptoms in the 
participants themselves and enuresis in their offspring, suggesting an association between these two 
disorders with possibly different underlying pathways. Second, the offspring of parents likely to have 
ADHD presented an elevated risk of having attempted suicide. Admittedly, the comparative 
performance of the three scoring algorithms contrasted here and developed in US populations need to 
be confirmed in a French-speaking sample against a clinical assessment of ADHD (e.g. the DIVA 
interview). In addition, our results suggest that epidemiological identification of persons likely to 
present clinically significant levels of ADHD should rely on an improved scoring algorithm taking 
into account not only the ASRS, but also impairment and deficits in executive functions. 
References 
Adler LA, Guida F, Irons S, Rotrosen J & O'Donnell K (2009) Screening and imputed prevalence of 
ADHD in adult patients with comorbid substance use disorder at a residential treatment 
facility. Postgraduate Medicine 121. 
Adler LA & Newcorn JH (2011) Administering and evaluating the results of the adult ADHD Self-
Report Scale (ASRS) in adolescents. Journal of Clinical Psychiatry 72:e20. 
Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Hammerness P, Sitt DJ, Davidow JV & Faraone SV 
(2012) Preliminary examination of the reliability and concurrent validity of the Attention-
Deficit/Hyperactivity disorder Self-Report Scale v1.1 symptom checklist to rate symptoms of 
Attention-Deficit/Hyperactivity Disorder in adolescents. Journal of Child and Adolescent 
Psychopharmacology 22:238-244. 
Agosti V, Chen Y & Levin FR (2011) Does Attention Deficit Hyperactivity Disorder increase the risk 
of suicide attempts? Journal of Affective Disorders 133:595-599. 
Altfas JR (2002) Prevalence of Attention Deficit/Hyperactivity Disorder among adults in obesity 
treatment. BMC Psychiatry 2:9. 
American Psychiatric Association (1994) Diagnosis and Statistical Manual of Mental Disorders, IV.). 
Washington, DC: American Psychiatric Press. 
Aubert D, Bérard E, Blanc J-P, Lenoir G, Liard F & Lottmann H (2010) Énurésie nocturne primaire 
isolée: diagnostic en prise en charge. Recommandations par consensus formalisé d'experts. 
Progrès en Urologie 20:343. 
Baeyens D, Roeyers H, D'Haese L, Pieters F, Hoebeke P & Vande Walle J (2006) The prevalence of 
ADHD in children with enuresis: comparison between tertiary and non-tertiary care sample. 
Acta Paediatrica 95:347-352. 
 
 
Baeyens D, Roeyers H & Demeyere I (2005) Attention-Deficit/Hyperactiviy Disorder (ADHD) as a 
risk factor for difficult to cure nocturnal enuresis in children: a two-year follow-up study. Acta 
Paediatrica 94:1619-1625. 
Baeyens D, Roeyers H, Hoebeke P, Verté S, van Hoecke E & Vande Walle J (2004) Attention 
deficit/hyperactivity disorder in children with nocturnal enuresis. The Journal of Urology 
171:2576-2579. 
Baeyens D, Roeyers H, Van Erdeghem S, Hoebeke P & Vande Walle J (2007) The prevalence of 
Attention Deficit-Hyperactivity Disorder in chidren with nonmonosymptomatic nocturnal 
enuresis: a 4-year followup study. The Journal of Urology 178:2616-2620. 
Barkley RA, Murphy KR & Fischer M (2008) ADHD in adults: what the science says.). New York: 
The Guilford Press. 
Berger I & Felsenthal-Berger N (2009) Attention-deficit hyperactivity disorder (ADHD) and birth 
order. Journal of Clinical Neurology 24:692-696. 
Biederman J, Petty C, Fried R, Fontanella J, Doyle AE, Seidman LJ & Faraone SV (2006) Impact of 
psychometrically defined deficits of executive functioning in adults with Attention-
Deficit/Hyperactivity Disorder. The American Journal of Psychiatry 163:1730-1738. 
Biederman J, Petty CR, Evans M, Small J & Faraone SV (2010) How persistent is ADHD? A 
controlled 10-year follow-up study of boys with ADHD. Psychiatry Research 177:299-304. 
Birtchnell J (1971) Birth rank and mental illness. Nature 234:485-487. 
Brown TE (2009) ADHD comorbidities: handbook for ADHD complications in children and adults., 
pp 456). Arlington, VA: American Psychiatric Publishing, Inc. 
Caci H, Bayle FJ & Bouchez J (2008) Adult ADHD : translation and factor analysis of the ASRS v1.1. 
European Psychiatry 23:367-8. 
Caci H, Bouchez J & Baylé FJ (2009) Inattentive symptoms of ADHD are related to evening 
orientation. Journal of Attention Disorders 13:36-41. 
Caci H, Mattéi V, Baylé FJ, Nadalet L, Dossios C, Robert P & Boyer P (2005) Impulsivity but not 
Venturesomeness is related to morningness. Psychiatry Research 134:259-265. 
Caci H, Morin AJS & Tran A (2013 (Ahead of print)) Teacher ratings of the ADHD-RS IV in a 
community sample: Results from the ChiP-ARD study. Journal of Attention Disorders. 
Caci H, Robert P & Boyer P (2004a) Novelty seekers and impulsives subjects are low in morningness. 
European Psychiatry 19:79-84. 
Caci H, Vallier E, Robert P & Dossios C (2004b) Impulsivity and affect in suicide attempters. A short-
term longitudinal study. The International Journal of Neuropsychopharmacology 7:S455. 
Capdevila-Brophy C, Artigas-Pallarés J, Navarro-Pastor JB, Garcia-Nonell K, Rigau-Ratera E & 
Obiols JE (2013 (Ahead of print)) ADHD Predominantly Inattentive Subtype with high 
sluggish cognitive tempo: a new clinical entity? Journal of Attention Disorders. 
Cortese S, Konofal E, Dalla Bernardina B, Mouren M-C & Lecendreux M (2008) Does excessive 
daytime sleepiness contribute to explaining the association between obesity and ADHD 
symptoms? Medical Hypotheses 70:12-16. 
Davis C, Levitan RD, Smith M, Tweed S & Curtis C (2006) Associations among overeating, 
overweight, and attention deficit/hyperactivity disorder: a structural equation modelling 
approach. Eating Behaviors 7:266-274. 
de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, Borges G, Demyttenaere K, 
Gasquet I, de Girolamo G, Haro JM, Jin R, Karam EG, Ormel J & Posada-Villa J (2008) The 
prevalence and effects of adult Attention-Deficit/Hyperactivity Disorder (ADHD) on the 
performance of workers: results from the WHO World Mental Health Survey Initiative. Occup 
Environ Med 65:835-842. 
de Zwaan M, Gruss B, Müller A, Philipsen A, Graap H, Martin A, Glaesmer H & Hilbert A (2011) 
Association between obesity and adult attention-deficit/hyperactivity disorder in a German 
community-based sample. Obesity Facts 4:204-211. 
DIVA Foundation (2012) Diagnostic interview for ADHD in adults.). The Hague. 
Docet MF, Larranaga A, Perez Mendez LF & Garcia-Mayor RV (2012) Attention deficit hyperactivity 




Erhart M, Herpertz-Dahlmann B, Wille N, Sawitzky-Rose B, Hölling H & Ravens-Sieberer U (2012) 
Examining the relationship between Attention-Deficit/Hyperactivity Disorder and overweight 
in children and adolescents. European Child and Adolescent Psychiatry 21:39-49. 
Faraone SV, Biederman J & Mick E (2006a) The age-dependent decline of attention-deficit 
hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 36:159-
165. 
Faraone sv, Biederman J, Spencer T, Mick E, Murray K, Petty C, Adamson JJ & Monuteaux MC 
(2006b) Diagnosing adult attention deficit hyperactivity disorder: are late onset and 
subthreshold diagnoses valid? American Journal of Psychiatry 163:1720-1729. 
Fayyad J, De Graaf R, Kessler J, Angermeyer AM, Demyttenaere K, De Girolamo G, Haro JM, 
Karam EC, Lara C, Lépine J-P, Ormel, Posada-Villa J, Zaslavsky AM & Jin R (2007) Cross-
national prevalence and correlates of adult attention-deficit hyperactivity disorder. Bristish 
Journal of Psychiatry 190:402-409. 
Galéra C, Côté SM, Bouvard MP, Pingault J-B, Melchior M, Michel G, Boivin M & Tremblay RE 
(2011) Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 
months to 8 years. Archives of General Psychiary 68:1267-1275. 
Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, Brown AK, 
Monterosso JR, Aron AR, Mandelkern MA, Poldrack RA & London ED (2012) Striatal 
dopamine D(2)/D(3) receptors mediate response inhibition and related activity in frontostriatal 
neural circuitry in humans. Journal of Neuroscience 32:7316-24. 
Gomez R & Hafetz N (2011) DSM-IV ADHD: Prevalence based on parent and teacher ratings of 
Malaysian primary school children. Asian Journal of Psychiatry 4:41-44. 
Gonon F, Guilé J-M & Cohen D (2010) Le trouble déficitaire de l'attention avec hyperactivité: 
données récentes des neurosciences et de l'expérience nord-américaine. Neuropsychiatrie de 
l'Enfant et de l'Adolescent 58:273-281. 
Gordon M, Antshel K, Faraone SV, Barkley RA, Lewandowski L, Hudziak JJ, Biederman J & 
Cunningham C (2006) Symptoms versus impairment: The case for respecting DSM-IV’s 
criterion D. Journal of Attention Disorders 9:465-475. 
Hodgkins P, Arnold LE, Shaw M, Caci H, Kahle J, Woods AG & Young S (2012) A systematic 
review of long-term outcomes in ADHD: global publication trends. Frontiers in Psychiatry 
2:1-17. 
James A, Lai FH & Dahl C (2004) Attention Deficit Hyperactivity Disorder and suicide: a review of 
possible associations. Acta Psychiatrica Scandinavica 110:408-415. 
Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, Howes MJ, Jin R, Vega WA, 
Walters EE, Wang P, Zaslavsky A & Zheng H (2004a) Clinical calibration of DSM-IV 
diagnoses in the World Mental Health (WMH) version of the World Health Organization 
(WHO) Composite International Diagnostic Interview (WMH-CIDI). International Journal of 
Methods in Psychiatric Research 13:122-139. 
Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer 
T, Ustun TB & Walters EE (2005) The World Health Organization adult ADHD self-report 
scale (ASRS): a short screening scale for use in the general population. Psychological 
Medicine 35:245-256. 
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, 
Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE & Zaslavsky AM (2006) The 
prevalence and correlates of adult ADHD in the United States: results from the national 
comorbidity survey replication. The American Journal Psychiatry 163:716-723. 
Kessler RC, Adler L, Gruber MJ, Sarawate CA, Spencer T & Van Brunt DL (2007) Validity of the 
World Health Organization Adult ADHD Self-Report Scale (ASRS) screener in a 
representative sample of health plan members. International Journal of Methods in Psychiatry 
Research 16:52-65. 
Kessler RC, Berglund P, Chiu WT, Demler O, Herringa S, Hiripi E, Jin R, Pennell B-E, Walters EE, 
Zaslavsky A & Zheng H (2004b) The US National Comorbidity Survey Replication (NCS-R): 




Klein RG, Mannuzza S, Ramos Olazagasti MA, Roizen E, Hutchinson JA, Lashua EC & Castellanos 
FX (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity 
disorder 33 years later. Archives of General Psychiary. 
Kooij SJJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, Edvinsson D, Fayyad J, 
Foeken K, Fitzgerald M, Gaillac V, Ginsberg Y, Henry C, Krause J, Lensing MB, Manor I, 
Niederhofer H, Nunes-Filipe C, Ohlmeier MD, Oswald P, Pallanti S, Pehlivanidis A, Ramos-
Quiroga JA, Rastam M, Ryffel-Rawak D, Stes S & Asherson P (2010) European consensus 
statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. 
BMC Psychiatry 10:67-91. 
Lewis JR & Sauro J (2006) When 100% really isn't 100%: improving the accuracy of small-sample 
estimates of completion rates. Journal of Usability Studies 3:136-150. 
Lindblad F, Ringbäck Weitoft G & Hjem A (2011) Maternal and paternal psychopathology increases 
risk of offspring ADHD equally. Epidemiology and Psychiatric Sciences 20:367-372. 
Mannuzza S, Klein RG, Bessler A, Malloy P & LaPadula M (1993) Adult outcome of hyperactive 
boys: educational achievement, occupational rank, and psychiatric status. Archives of General 
Psychiatry 50:565-576. 
Marin AM, Seco FL, Serrano SM, Garcia SA, Gaviria Gomez AM & Ney I (2012 [Epub ahead of 
print]) Do firstborn children have an increased risk of ADHD? Journal of Attention Disorders. 
McClure HH, Eddy JM, Kjellstrand JM, Snodgrass JJ & Martinez CRJ (2012) Chid and adolescent 
affective and behavioral distress and elevated adult body mass index. Child Psychiatry and 
Human Development 43:837-854. 
Mikami AY, Hinshaw SP, Arnold LE, Hoza B, Hechtman L, Newcorn JH & Abikoff HB (2010) 
Bulimia nervosa symptoms in the Multimodal Treatment Study of Children with ADHD. 
International Journal of Eating Disorders 43:248-259. 
Molina BSG, Hinshaw SP, Swanson JM, Arnorld LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, 
Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, 
Gibbons RD, Hur K, Houck PR & The MTA Cooperative Group (2009) The MTA at 8 years: 
prospective follow-up of children treated for Combined Type ADHD in a multisite study. 
Journal of the American Academy of Child and Adolescent Psychiatry 48:484-500. 
Morin AJS, Tran A & Caci H (2013 (Ahead of print)) Factorial Validity of the ADHD Adult 
Symptom Rating Scale in a French community sample: Results from the ChiP-ARD study. 
Journal of Attention Disorders. 
Natale V, Ballardini D, Schumann R, Mencarelli C & Magelli V (2008) Morningness-eveningness 
preference and eating disorders. Personality and Individual Differences 45:549-553. 
Nazar BP, Moreira de Sousa Pina C, Coutinho G, Segenreich D, Duchesne M, Appolinario JC & 
Mattos P (2008) Review of literature of Attention-Deficit/Hyperactivity Disorder with 
comorbid eating disorders. Rev Bras Psiquiatr 30:384-389. 
Nazar BP, Pinna CM, Suwwan R, Duchesne M, Freitas SR, Sergeant J & Mattos P (2012 [Epub ahead 
of print]) ADHD rate of obese women with binge eating and bulimic behaviors from a weight-
loss clinic. Journal of Attention Disorders. 
Pagoto SL, Curtin C, Lemon SC, Bandini LG, Schneider KL, Bodenlos JS & Ma Y (2009) 
Association between adult Attention Deficit/Hyperactivity Disorder and obesity in the US 
population. Obesity 17:539-544. 
Philipsen A, Hornyak M & Riemann D (2006) Sleep and sleep disorders in adults with attention 
deficit/hyperactivity disorder. Sleep Medicine Reviews 10:399-405. 
Polanczyk G, Silva de Lima M, Lessa Horta B, Biederman J & Rohde LA (2007) The worldwide 
prevalence of ADHD: a systematic review and metaregression analysis. The American Journal 
of Psychiatry 164:942-948. 
Poulton A, Briody J, McCorquodale T, Melzer E, Herrmann M, Baur LA & Duque G (2012) Weight 
loss on stimulant medication: how does it affect body composition and bone metabolism? A 
prospective longitudinal study. International Journal of Pediatric Endocrinology 30. 
Sauro J & Lewis JR (2005) Estimating completion rates from small samples using binomial 
confidence intervals: comparisons and recommandations. In HFES (Ed), Proceedings of the 
Human Factors and Ergonomics Social Annual Meeting). Orlando, FL. 
 
 
Seidman LJ, Biederman J, Weber W, Hatch M & Faraone SV (1998) Neuropsychological function in 
adults with attention-deficit hyperactivity disorder. Biol Psychiatry 44:260-8. 
Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG & Arnold LE (2012) A systematic 
review and analysis of long-term outcomes in ADHD: effects of treatment and non-treatment. 
BMC Medicine 10. 
Simon V, Czobor P, Bàlint S, Mészàros A & Bitter I (2009) Prevalence and correlates of adult 
attention-deficit hyperactivity disorder: meta-analysis. British journal of Psychiatry 194:204-
211. 
Solanto MV (2000) The predominantly inattentive subtype of attention-deficit/hyperactivity disorder. 
CNS Spectrums 5:45-51. 
Stata Corp. (2007) Stata Statistical Sofware: Release 9.2.). College Station, TX: Stata Press. 
Stice E, Yokum S, Zald D & Dagher A (2011) Dopamine-based reward circuitry responsivity, 
genetics, and overeating. Current Topics in Behavioral Neurosciences 6:81-93. 
Surman CBH, Randall ET & Biederman J (2006) Association between attention-deficit/hyperactivity 
disorder and bulimia nervosa: analysis of 4 case-control studies. Journal of Clinical 
Psychiatry 67:351-354. 
Swensen AR, Allen AJ, Kruesi MJ, Purdum A & Goldberg G (2002) Increased risk of self-injuray and 
suicide risk for patients with Attention-Deficit/Hyperactivity Disorder. European 
Neuropsychopharmacology 12:S421. 
van Buuren S, Boshuizen HC & Knook DL (1999) Multiple imputation of missing blood pressure 
covariates in survival analysis. Statistics in Medicine 18:681-694. 
Vansteelandt K, Pieters G, Vandereycken W, Claes L, Probst M & van Mechelen I (2004) 
Hyperactivity in anorexia nervosa: a case study using experience sampling methodology. 
Eating Disorders 5:67-74. 
Wahlstedt C, Thorell LB & Bohlin G (2009) Heterogeneity in ADHD: neuropsychological pathways, 
comorbidity and symptom domains. Journal of Abnormal Child Psychology 37:551-564. 
Waring ME & Lapane KL (2008) Overweight in children and adolescents in relation to Attention-
Deficit/Hyperactivity Disorder: results from a national sample. Pediatrics 122:e1-e5. 
Weintraub Y, Singer S, Alexander D, Hacham S, Menuchin G, Lubetzky R, Steinberg DM & Pinhas-
Hamiel O (2013) Enuresis - an unattended comorbidity of childhood obesity. International 
Journal of Obesity 37:75-78. 
White IR, Royston P & Wood AM (2011) Multiple imputation using chained equations: issues and 
guidance for practice. Statistics in Medicine 30:377-399. 
Wonderlich SA, Connolly KM & Stice E (2004) Impulsivity as a risk factor for eating disorder 
behavior: assessment implications with adolescents. International Journal of Eating Disorders 
36:172-182. 
Word Health Organization (1993) The ICD-10 Classification of Mental and Behavioral Disorders: 
Diagnostic Criteria for Research.). Geneva, Switzerland: World Health Organization. 
Xu X, Breen G, Chen C-K, Huang Y-S, Wy Y-Y & Asherson P (2010) Association study between a 
polymorphism at the 3'-untranslated region of CLOCK gene and Attention-
Deficit/Hyperactivity Disorder. Behavioral and Brain Functions 6:48-52. 
 
 
